Form 4: NeuroPace Inc. Executive Martha Morrell Reports Stock Transaction
SEC Form 4 Filing
Chief Medical Officer Martha Morrell of NeuroPace Inc. reports disposition of shares to cover tax obligations.
Summary
- On March 3, 2025, Martha Morrell, Chief Medical Officer of NeuroPace Inc., reported a transaction involving the company's common stock.
- Morrell disposed of 1,337 shares at a price of $11.81 per share to satisfy tax obligations.
- Following the transaction, Morrell directly owns 79,226 shares of NeuroPace Inc. common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing a stock transaction by an executive. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of the US stock market and are required by the SEC to provide transparency into the transactions of company insiders.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on stakeholders as it is a routine sale of shares by an executive.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Date of stock transaction |
| 03/05/2025 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.